No association of Presenilin-1 intronic polymorphism and Alzheimer's disease in Australia
K Taddei, D Yang, C Fisher, R Clarnette, J Hallmayer, R Barnetson, R Maller, WS Brooks, S Whyte, GA Nicholson, CL Masters, GA Broe, SE Gandy, RN Martins
Neuroscience Letters | ELSEVIER SCI IRELAND LTD | Published : 1998
We screened 703 Australian subjects for an intronic polymorphism in the presenilin-1 (PS-1) gene. PS-1 intronic allele 1 homozygosity was not associated with individuals with early- or late-onset sporadic Alzheimer's disease (EOAD or LOAD). Carriers for the PS-1 intronic allele 1 were also not associated with significantly increased risk for AD regardless of gender. Our results for the Australian population are consistent with those of recent reports for other populations and do not support the conclusion that the PS-1 intronic polymorphism is associated with AD.
Awarded by NATIONAL INSTITUTE ON AGING
Awarded by NIA NIH HHS